Verbatim response from ChatGPT
Short answer: It depends on which biomarkers, your age, and your risk/health status. Below is a practical guide you can use to make a plan and discuss with your clinician.
General principles
- Get a baseline set of labs once (if you haven’t recently). How often after that depends on risk, new symptoms, and treatment changes.
- Re-test sooner when a result is abnormal, when you start or change a medication, or after a big lifestyle change you want to track (weight loss, new diet, starting exercise).
- For chronic conditions (diabetes, hypothyroidism, heart disease) testing is more frequent and dictated by treatment goals.
Suggested frequencies by biomarker (typical/average)
- Basic metabolic panel (electrolytes, kidney function, liver enzymes): baseline, then annually if healthy; sooner (weeks–months) if abnormal or after starting medications that affect kidneys/liver.
- Lipid panel (total cholesterol, LDL, HDL, triglycerides): baseline, then every 4–6 years if low risk and normal; every 1 year if you’re on lipid-lowering therapy or have cardiovascular risk factors; 6–12 weeks after starting/changing a statin to check response, then every 6–12 months while titrating, then annually.
- Hemoglobin A1c: every 3 months if you’re starting or changing diabetes therapy or not at goal; every 6 months if diabetes is stable and at goal; if you have prediabetes, check about every 6–12 months.
- Fasting glucose: as part of routine screening every 3 years from age 45 if normal (earlier/more often if overweight or other risk factors).
- Complete blood count (CBC): baseline and then annually if healthy; sooner if symptoms (fatigue, bleeding) or if on medications that affect blood counts.
- Thyroid tests (TSH +/- free T4): if symptomatic or risk factors, check; if on or starting levothyroxine, test 6–12 weeks after dose changes, then every 6–12 months when stable.
- Vitamin D: recheck about 8–12 weeks after starting supplementation to see response, then maybe every 6–12 months if maintained.
- CRP/hs-CRP or other inflammatory markers: not routine for everyone—use per clinician for risk stratification or to follow inflammatory disease activity.
- PSA (men): follow shared decision-making with your clinician—commonly done every 1–2 years in those being screened (55–69) or as recommended by urologist.
- Drug-specific monitoring: warfarin requires frequent INR checks per protocol; statins may need baseline LFTs and symptom-directed follow-up.
When to test more often
- New or worsening symptoms (fatigue, weight change, palpitations, swelling, etc.).
- Abnormal result — repeat sooner (days to months) depending on severity.
- Starting/changing medication that affects the biomarker.
- Significant lifestyle change and you want to measure impact — e.g., recheck metabolic labs or lipids ~3 months after diet/exercise program.
Practical tips
- Make a testing plan with your primary care clinician so you know which tests and how often.
- Keep copies of past labs to track trends (many labs let you download results).
- If you want convenient testing, you can use major lab networks like LabCorp or Quest Diagnostics (broad test menus and physician orders). For home/self-collection kits, Everlywell and LetsGetChecked are widely used (convenient but check what tests they cover). For deeper interpretation and coaching, services such as InsideTracker or WellnessFX provide trend analysis and recommendations.
- If you don’t have a PCP, telemedicine services (One Medical, Teladoc) can order and interpret labs and set a follow-up schedule.
If you want, tell me your age, major health conditions and any medications you’re on and I’ll suggest a personalized retesting schedule.